Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for AMPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 42.53M
March 31, 2026 44.64M
December 31, 2025 45.65M
September 30, 2025 46.35M
June 30, 2025 46.49M
March 31, 2025 47.67M
December 31, 2024 47.62M
September 30, 2024 48.37M
June 30, 2024 48.96M
March 31, 2024 48.84M
December 31, 2023 48.07M
September 30, 2023 47.90M
June 30, 2023 48.82M
March 31, 2023 48.18M
December 31, 2022 48.11M
September 30, 2022 48.61M
June 30, 2022 48.99M
March 31, 2022 48.75M
December 31, 2021 47.71M
September 30, 2021 47.98M
June 30, 2021 47.98M
March 31, 2021 47.72M
December 31, 2020 47.50M
September 30, 2020 47.53M
June 30, 2020 47.49M
Date Value
March 31, 2020 46.31M
December 31, 2019 46.58M
September 30, 2019 47.20M
June 30, 2019 47.22M
March 31, 2019 47.10M
December 31, 2018 46.63M
September 30, 2018 46.16M
June 30, 2018 46.42M
March 31, 2018 46.66M
December 31, 2017 46.62M
September 30, 2017 45.90M
June 30, 2017 46.25M
March 31, 2017 45.96M
December 31, 2016 46.25M
September 30, 2016 46.04M
June 30, 2016 45.09M
March 31, 2016 44.94M
December 31, 2015 45.20M
September 30, 2015 45.21M
June 30, 2015 45.33M
March 31, 2015 44.66M
December 31, 2014 44.65M
September 30, 2014 44.65M
June 30, 2014 44.64M
March 31, 2014 43.41M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 1.155B
Supernus Pharmaceuticals, Inc. 58.16M
Liquidia Corp. 89.10M
ANI Pharmaceuticals, Inc. 22.97M
Corcept Therapeutics, Inc. 107.92M